Literature DB >> 21485761

Reflections and proposals to assure quality in molecular diagnostics.

M Raymaekers1, M Bakkus, E Boone, B de Rijke, H El Housni, P Descheemaeker, P De Schouwer, S Franke, F Hillen, F Nollet, O Soetens, A Vankeerberghen.   

Abstract

Molecular diagnostic testing has become an important tool in clinical laboratories. Accreditation according to the international quality standard ISO15189:2007 for medical laboratories is required for reimbursement of several molecular diagnostic tests in Belgium. Since the ISO15189:2007 standard applies to medical laboratories in general, the particular requirements for quality and competence are mentioned in general terms, not taking into account the specificities of molecular biology testing. Therefore, the working group "MolecularDiagnostics.be" described a consensus interpretation of chapter 5, Technical requirements, of the ISO standard for application in molecular diagnostic laboratories. The manuscript can be used as an instrument to prepare internal and external audits that meet the 15015189:2007 (chapter 5) criteria.

Mesh:

Year:  2011        PMID: 21485761     DOI: 10.2143/ACB.66.1.2062511

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

1.  Evaluation of a standardised real-time PCR based DNA-detection method (Realstar®) in whole blood for the diagnosis of primary human cytomegalovirus (CMV) infections in immunocompetent patients.

Authors:  M Berth; I Benoy; N Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-10       Impact factor: 3.267

Review 2.  Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe.

Authors:  Hendrikus J Dubbink; Zandra C Deans; Bastiaan B J Tops; Folkert J van Kemenade; S Koljenović; Han J M van Krieken; Willeke A M Blokx; Winand N M Dinjens; Patricia J T A Groenen
Journal:  Mol Oncol       Date:  2014-03-18       Impact factor: 6.603

3.  One-day workflow scheme for bacterial pathogen detection and antimicrobial resistance testing from blood cultures.

Authors:  Wendy L J Hansen; Judith Beuving; Annelies Verbon; Petra F G Wolffs
Journal:  J Vis Exp       Date:  2012-07-09       Impact factor: 1.355

4.  Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Authors:  Javier Simarro; Rosa Murria; Gema Pérez-Simó; Marta Llop; Nuria Mancheño; David Ramos; Inmaculada de Juan; Eva Barragán; Begoña Laiz; Enrique Cases; Emilio Ansótegui; José Gómez-Codina; Jorge Aparicio; Carmen Salvador; Óscar Juan; Sarai Palanca
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.